查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2020331

過敏免疫療法市場規模、佔有率、成長及全球產業分析：按類型、應用和地區的洞察，2026-2034年的預測

Allergy Immunotherapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 129 Pages | 商品交期: 請詢問到貨日

價格

過敏免疫療法市場的成長要素

全球過敏免疫療法市場在2025年達到19.9億美元，預計2026年成長至21.7億美元，到2034年達到51.4億美元，2026年至2034年間年複合成長率將達到11.38%。市場成長的主要促進因素是過敏性疾病（如過敏性鼻炎、氣喘和食物過敏）的盛行率不斷上升，以及人們對長期治療方法的認知不斷提高。

過敏免疫療法，也稱為過敏原脫敏療法，是指重複給予過敏原以降低免疫系統的敏感性。這種療法有助於預防由花粉、塵蟎和昆蟲叮咬等過敏原引發的嚴重過敏反應。

主要市場趨勢

到2025年，歐洲將引領市場，佔據全球71.08%的佔有率，這主要得益於強力的保險償付政策、較高的過敏症盛行率以及大量的研發投入。皮下免疫療法（SCIT）因其療效已得到證實，將佔據最大佔有率；而舌下免疫療法（SLIT）則因其給藥方便、患者依從性高，預計將實現最快成長。

由於人們意識的提高、監管的進步和產品平臺的擴大，日本、美國和中國等國家成為主要貢獻者。

市場趨勢

影響市場格局的關鍵趨勢之一是舌下免疫療法（SLIT）向片劑和眼藥水的轉變。與傳統的過敏注射療法（SCIT）相比，SLIT具有許多優勢，例如使用方便、全身反應風險更低以及可在家給藥。

為了滿足日益成長的市場需求，製藥公司加大對舌下含服（SLIT）產品研發的投資。醫生越來越傾向於使用SLIT療法，尤其是在治療對單一過敏原過敏的患者時，這進一步推動了這一趨勢。

市場促進因素

全球過敏症盛行率的不斷上升是推動市場成長的主要因素。研究表明，過敏性鼻炎影響全球約25%至40%的人口。環境變化、污染和生活方式因素導致人們接觸過敏原的機會顯著增加。

此外，政府加強投入、提供更多財政支持並進行宣傳宣傳活動，加速早期診斷和治療。生物技術公司和製藥公司之間的策略合作也在加速創新並拓展治療選擇。

市場限制因素

儘管該市場成長潛力巨大，但仍面臨諸多挑戰，例如治療費用高昂和患者用藥依從性低。免疫療法需要長期治療，這使得許多患者無法完成整個療程。

尤其是在一些國家，諸如SLIT（口服免疫療法）眼藥水等新型治療方法的醫保覆蓋範圍有限，進一步限制了患者的獲得。 SCIT（皮下免疫療法）的副作用以及頻繁就醫帶來的不便也影響了其普及率。

細分分析

依類型

  • 皮下免疫療法（SCIT）：由於其療效高、臨床接受度高，預計到2026年將佔據市場主導地位。
  • 舌下免疫療法（SLIT）：由於便利性、安全性和產品核可，預計將快速成長。

依用途

  • 過敏性鼻炎：由於其高發病率，預計到2026年將成為最大的細分市場，佔市場佔有率的68.83%。
  • 過敏性氣喘及其他疾病：由於研發投入增加及治療適應症擴大，預計將維持穩定成長。

依通路

  • 零售藥局和網路藥局：由於其便利性和可近性，預計到2026年，它們將主導市場，佔據 86.75%的市場佔有率。
  • 醫院藥局：隨著住院病人數量的增加，預計將穩定成長。

區域分析

  • 歐洲：在強大的醫療保健基礎設施和償付政策的支持下，它是最大的市場，預計到2025年將達到 14.2億美元。
  • 亞太地區：由於人們意識的提高和過敏負擔的加重，該地區是成長最快的地區。
  • 北美：在高診斷率和先進治療方法的推動下，預計將顯著成長。
  • 拉丁美洲、中東和非洲：由於醫療保健系統的改善和政府舉措，預計將實現溫和成長。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 主要疾病（食物過敏、過敏性鼻炎等）盛行率：依主要國家分類，2025/2026年
  • 主要企業管道分析
  • 產業重大發展動態 - 併購與合作
  • 新產品發布：依主要企業分類
  • 新冠疫情對市場的影響

第5章 2021-2034年全球過敏免疫療法市場分析、洞察與預測

  • 市場分析、洞察與預測：依類型
    • 皮下免疫療法
    • 舌下免疫療法
  • 市場分析、洞察與預測：依應用領域分類
    • 過敏性鼻炎
    • 過敏性氣喘
    • 其他
  • 市場分析、洞察與預測：依通路分類
    • 醫院藥房
    • 實體店和網路藥局
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美過敏免疫療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲過敏免疫療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 波蘭
    • 瑞典
    • 挪威
    • 丹麥
    • 其他歐洲國家

第8章 亞太地區過敏免疫療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國
    • 東南亞
    • 其他亞太國家

第9章 拉丁美洲過敏免疫療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 哥倫比亞
    • 其他拉丁美洲國家

第10章 中東和非洲過敏免疫療法市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • ALK
    • Stallergenes Greer
    • Allergy Therapeutics
    • HAL Allergy BV
    • HollisterStier Allergy
    • Zhejiang Wolwo Bio-pharmaceutical Co.,Ltd
    • LETIPharma
    • Dermapharm Holding SE
Product Code: FBI100727

Growth Factors of allergy immunotherapy Market

The global allergy immunotherapy market was valued at USD 1.99 billion in 2025 and is projected to grow to USD 2.17 billion in 2026, reaching USD 5.14 billion by 2034, exhibiting a robust CAGR of 11.38% during 2026-2034. The market growth is primarily driven by the increasing prevalence of allergic diseases such as allergic rhinitis, asthma, and food allergies, along with rising awareness regarding long-term treatment solutions.

Allergy immunotherapy, also known as allergen desensitization, involves repeated administration of allergens to reduce immune sensitivity. This therapy helps in preventing severe allergic reactions caused by triggers such as pollen, dust mites, and insect stings.

Key Market Insights

Europe dominated the global market in 2025, accounting for 71.08% share, supported by strong reimbursement policies, high allergy prevalence, and significant research investments. Subcutaneous immunotherapy (SCIT) held the largest share due to its proven efficacy, while sublingual immunotherapy (SLIT) is expected to witness the fastest growth due to ease of administration and improved patient compliance.

Countries such as Japan, the U.S., and China are emerging as key contributors due to increasing awareness, regulatory advancements, and expanding product pipelines.

Market Trends

A major trend shaping the market is the shift toward sublingual immunotherapy (SLIT) tablets and drops. Compared to traditional allergy shots (SCIT), SLIT offers advantages such as convenience, reduced risk of systemic reactions, and at-home administration.

Pharmaceutical companies are increasingly investing in SLIT product development to meet growing demand. The rising physician preference for prescribing SLIT therapies further supports this trend, especially for patients with single-allergen sensitivities.

Market Drivers

The increasing global prevalence of allergies is a key factor driving market growth. Studies indicate that allergic rhinitis affects nearly 25%-40% of the global population. Environmental changes, pollution, and lifestyle factors have significantly increased exposure to allergens.

Additionally, growing government initiatives, funding support, and awareness campaigns are encouraging early diagnosis and treatment. Strategic collaborations between biotech firms and pharmaceutical companies are also accelerating innovation and expanding treatment options.

Market Restraints

Despite strong growth potential, the market faces challenges such as high treatment costs and low patient adherence. Immunotherapy requires long-term commitment, which discourages many patients from completing treatment cycles.

Limited insurance coverage, especially for newer therapies like SLIT drops in certain countries, further restricts accessibility. Adverse effects and inconvenience associated with frequent clinic visits for SCIT also impact adoption rates.

Segmentation Analysis

By Type

  • SCIT (Subcutaneous Immunotherapy): Dominated the market in 2026 with high efficacy and long-standing clinical acceptance.
  • SLIT (Sublingual Immunotherapy): Expected to grow rapidly due to convenience, safety, and increasing product approvals.

By Application

  • Allergic Rhinitis: Largest segment with 68.83% share in 2026, driven by high disease prevalence.
  • Allergic Asthma & Others: Expected to grow steadily due to rising R&D investments and expanding treatment indications.

By Distribution Channel

  • Retail & Online Pharmacies: Dominated with 86.75% share in 2026 due to accessibility and convenience.
  • Hospital Pharmacies: Witnessing steady growth supported by increasing hospital admissions.

Regional Analysis

  • Europe: Largest market with USD 1.42 billion in 2025, driven by strong healthcare infrastructure and reimbursement policies.
  • Asia Pacific: Fastest-growing region due to rising awareness and increasing allergy burden.
  • North America: Significant growth supported by high diagnosis rates and advanced treatment adoption.
  • Latin America & Middle East & Africa: Gradual growth due to improving healthcare systems and government initiatives.

Competitive Landscape

The market is semi-consolidated with key players such as ALK, Stallergenes Greer, Allergy Therapeutics, and Dermapharm. These companies focus on strategic partnerships, R&D investments, and product innovation to strengthen their market presence.

Conclusion

The global allergy immunotherapy market is set for strong growth from USD 1.99 billion in 2025 to USD 5.14 billion by 2034, driven by rising allergy prevalence, increasing awareness, and advancements in treatment options. While challenges such as high costs and low adherence persist, the growing adoption of convenient therapies like SLIT and continuous innovation by key players are expected to transform the treatment landscape. Overall, the market presents significant opportunities, particularly in emerging regions, as healthcare access and patient awareness continue to improve.

Segmentation By Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

By Application

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies & Online Pharmacies

By Geography

  • North America (By Type, By Application, By Distribution Channel, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Poland
    • Sweden
    • Norway
    • Denmark
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By Distribution Channel, By Country /Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Conditions (Food Allergy, Allergic Rhinitis, etc.), By Key Countries/Regions, 2025/ 2026
  • 4.2. Pipeline Analysis, By Key Players
  • 4.3. Key Industry Developments- Merger, Acquisitions, and Partnerships
  • 4.4. New Product Launches, By Key Players
  • 4.5. Impact of COVID-19 on the Market

5. Global Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Subcutaneous Immunotherapy
    • 5.1.2. Sublingual Immunotherapy
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Allergic Rhinitis
    • 5.2.2. Allergic Asthma
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Hospital Pharmacies
    • 5.3.2. Retail and Online Pharmacies
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Subcutaneous Immunotherapy
    • 6.1.2. Sublingual Immunotherapy
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Allergic Rhinitis
    • 6.2.2. Allergic Asthma
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Hospital Pharmacies
    • 6.3.2. Retail and Online Pharmacies
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Subcutaneous Immunotherapy
    • 7.1.2. Sublingual Immunotherapy
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Allergic Rhinitis
    • 7.2.2. Allergic Asthma
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail and Online Pharmacies
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Netherlands
    • 7.4.7. Belgium
    • 7.4.8. Poland
    • 7.4.9. Sweden
    • 7.4.10. Norway
    • 7.4.11. Denmark
    • 7.4.12. Rest of Europe

8. Asia Pacific Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Subcutaneous Immunotherapy
    • 8.1.2. Sublingual Immunotherapy
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Allergic Rhinitis
    • 8.2.2. Allergic Asthma
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail and Online Pharmacies
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Australia
    • 8.4.4. Japan
    • 8.4.5. South Korea
    • 8.4.6. Southeast Asia
    • 8.4.7. Rest of Asia Pacific

9. Latin America Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Subcutaneous Immunotherapy
    • 9.1.2. Sublingual Immunotherapy
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Allergic Rhinitis
    • 9.2.2. Allergic Asthma
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail and Online Pharmacies
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Colombia
    • 9.4.4. Rest of Latin America

10. Middle East & Africa Allergy Immunotherapy Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Subcutaneous Immunotherapy
    • 10.1.2. Sublingual Immunotherapy
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Allergic Rhinitis
    • 10.2.2. Allergic Asthma
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail and Online Pharmacies
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. ALK
      • 11.2.1.1. Product
      • 11.2.1.2. Overview
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Stallergenes Greer
      • 11.2.2.1. Product
      • 11.2.2.2. Overview
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. Allergy Therapeutics
      • 11.2.3.1. Product
      • 11.2.3.2. Overview
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. HAL Allergy B.V.
      • 11.2.4.1. Product
      • 11.2.4.2. Overview
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. HollisterStier Allergy
      • 11.2.5.1. Product
      • 11.2.5.2. Overview
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. Zhejiang Wolwo Bio-pharmaceutical Co.,Ltd
      • 11.2.6.1. Product
      • 11.2.6.2. Overview
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. LETIPharma
      • 11.2.7.1. Product
      • 11.2.7.2. Overview
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)
    • 11.2.8. Dermapharm Holding SE
      • 11.2.8.1. Product
      • 11.2.8.2. Overview
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. financials (Based on Availability)

List of Tables

  • Table 01: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 02: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 03: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
  • Table 04: Global Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 05: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 06: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 07: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
  • Table 08: North America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 09: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 10: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
  • Table 12: Europe Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 13: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 14: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 15: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
  • Table 16: Asia Pacific Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 17: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 18: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
  • Table 20: Latin America Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 21: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034
  • Table 24: Middle East & Africa Allergy Immunotherapy Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Allergy Immunotherapy Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
  • Figure 02: Global Allergy Immunotherapy Market Value Share (%), By Type, 2026 & 2034
  • Figure 03: Global Allergy Immunotherapy Market Value Share (%), By Application, 2026 & 2034
  • Figure 04: Global Allergy Immunotherapy Market Value Share (%), By Distribution Channel, 2026 & 2034
  • Figure 05: Global Allergy Immunotherapy Market Value (USD billion), By Region, 2026 & 2034
  • Figure 06: North America Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
  • Figure 07: North America Allergy Immunotherapy Market Value Share (%), by Type, 2025
  • Figure 08: North America Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
  • Figure 09: North America Allergy Immunotherapy Market Value Share (%), by Application, 2025
  • Figure 10: North America Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
  • Figure 11: North America Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
  • Figure 12: North America Allergy Immunotherapy Market Value (USD billion), by Country, 2026 & 2034
  • Figure 13: North America Allergy Immunotherapy Market Value Share (%), by Country, 2025
  • Figure 14: Europe Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
  • Figure 15: Europe Allergy Immunotherapy Market Value Share (%), by Type, 2025
  • Figure 16: Europe Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
  • Figure 17: Europe Allergy Immunotherapy Market Value Share (%), by Application, 2025
  • Figure 18: Europe Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
  • Figure 19: Europe Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
  • Figure 20: Europe Allergy Immunotherapy Market Value (USD billion), by Country/ Sub-region, 2026 & 2034
  • Figure 21: Europe Allergy Immunotherapy Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
  • Figure 23: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
  • Figure 25: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
  • Figure 27: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
  • Figure 28: Asia Pacific Allergy Immunotherapy Market Value (USD billion), by Country/Sub-region, 2026 & 2034
  • Figure 29: Asia Pacific Allergy Immunotherapy Market Value Share (%), by Country/Sub-region, 2025
  • Figure 30: Latin America Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
  • Figure 31: Latin America Allergy Immunotherapy Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
  • Figure 33: Latin America Allergy Immunotherapy Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
  • Figure 35: Latin America Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
  • Figure 36: Latin America Allergy Immunotherapy Market Value (USD billion), by Country/Sub-region, 2026 & 2034
  • Figure 37: Latin America Allergy Immunotherapy Market Value Share (%), by Country/Sub-region, 2025
  • Figure 38: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Type, 2026 & 2034
  • Figure 39: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Application, 2026 & 2034
  • Figure 41: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Distribution Channel, 2026 & 2034
  • Figure 43: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Distribution Channel, 2025
  • Figure 44: Middle East & Africa Allergy Immunotherapy Market Value (USD billion), by Country/Sub-region, 2026 & 2034
  • Figure 45: Middle East & Africa Allergy Immunotherapy Market Value Share (%), by Country/Sub-region, 2025
  • Figure 46: Global Allergy Immunotherapy Market Share (%), By Company, 2025